Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 12, 2013, Pages 1346-1348

  Sekiguchi, Yukari ^a   Misawa, Sonoko ^a   Shibuya, Kazumoto ^a   Nasu, Saiko ^a   Mitsuma, Satsuki ^a   Iwai, Yuta ^a   Beppu, Minako ^a   Sawai, Setsu ^a   Ito, Shoichi ^a   Hirano, Shigeki ^a   Nakaseko, Chiaki ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; MELPHALAN; PREDNISOLONE; THALIDOMIDE; VASCULOTROPIN; VINCRISTINE;

ADULT; AGED; ARTICLE; ASCITES; CASE STUDY; CLINICAL ARTICLE; DEATH; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERIPHERAL EDEMA; PLEURA EFFUSION; POEMS SYNDROME; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

EID: 84888071151     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304874     Document Type: Article

References (20)

1. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998;21:1390-7.
2. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004;104:3400-7.
3. Kuwabara S, Dispenzieri A, Arimura K, et al. Treatment for POEMS syndrome. Cochrane Database Syst Rev 2008;4:CD006828.
4. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005;106:1135.
5. Badros A. Bevacizumab therapy for POEMS syndrome (author reply). Blood 2006;107:4973-4.
6. Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood 2006;107:4972-3.
7. Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol 2012;87:804-14.
8. Kanai K, Kuwabara S, Misawa S, et al . Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Intern Med 2007;46:311-13.
9. Ohwada C, Nakaseko C, Sakai S, et al. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transplant 2009;43:739-40.
10. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-506.
11. Dietrich PY, Duchosal MA. Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome. Ann Oncol 2008;19:595.
12. Buxhofer-Ausch V, Gisslinger B, Stangl G, et al. Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndrome. Leuk Res 2012;36:e98-100.
13. Chahin N, Zeldenrust SR, Amrami KK, et al. Two causes of demyelinating neuropathy in one patient: CMT1A and POEMS syndrome. Can J Neurol Sci 2007;34:380-5.
14. Ropper AH, Raje NS, Lawrimore TM, et al. Case records of the Massachusetts General Hospital. Case 7-2010. A 49-year-old man with peripheral neuropathy and ascites. N Engl J Med 2010;362:929-40.
15. D'Souza A, Hayman SR, Buadi F, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 2011;118:4663-5.
16. Samaras P, Bauer S, Stenner-Liewen F, et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007;92:1438-9.
17. Chong DY, Comer GM, Trobe JD. Optic disc edema, cystoid macular edema, and elevated vascular endothelial growth factor in a patient with POEMS syndrome. J Neuroophthalmol 2007;27:180-3.
18. Gherardi RK, Bélec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996;87:1458-65.
19. Yamada Y, Sawai S, Misawa S, et al. Multiple angiogenetic factors are upregulated in POEMS syndrome. Ann Hematol 2013;92:245-8.
20. Kanai K, Sawai S, Sogawa K, et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology 2012;79:575-82.